selected publications
- Impact of radiotherapy dose, fractionation and immunotherapeutic partner in a mouse model of HR+ mammary carcinogenesis. Journal of the National Cancer Institute. 2024 Academic Article GET IT
- Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids. Journal of visualized experiments : JoVE. 2024 Academic Article GET IT
- Tumor-Associated Lymphocytes and Breast Cancer Survival in Black and White Women. JAMA surgery. 2024 Academic Article GET IT
- Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer. The Journal of pathology. 2024 Review GET IT
- The next chapter in immunotherapy and radiation combination therapy - cancer-specific perspectives. International journal of radiation oncology, biology, physics. 2024 Review GET IT
- The crosstalk between DNA repair and immune responses. Molecular cell. 2023 Academic Article GET IT
- CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor response. Oncoimmunology. 2023 Academic Article GET IT
- Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors. Nature communications. 2023 Academic Article GET IT
-
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group.
The Journal of pathology.
2023
Review
GET IT
Times cited: 2 -
Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
The Journal of pathology.
2023
Review
GET IT
Times cited: 1 - Multi-Institutional Evaluation of Pathologists' Assessment Compared to Immunoscore. Cancers. 2023 Academic Article GET IT
- The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Science immunology. 2023 Review GET IT
-
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.
Oncoimmunology.
2023
Review
GET IT
Times cited: 2 - Immunologically relevant effects of radiation therapy on the tumor microenvironment. Essays in biochemistry. 2023 Academic Article GET IT
- Pipeline to identify neoantigens exposed by radiation. Methods in cell biology. 2023 Academic Article GET IT
-
Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer.
Frontiers in oncology.
2023
Review
GET IT
Times cited: 4 - Quantitative assessment of mitophagy in irradiated cancer cells. Methods in cell biology. 2022 Academic Article GET IT
- Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021. Journal of translational medicine. 2022 Academic Article GET IT
- ATM Modulates Nuclear Mechanics by Regulating Lamin A Levels. Frontiers in cell and developmental biology. 2022 Academic Article GET IT
- The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021. Journal of translational medicine. 2022 Academic Article GET IT
- Radiation therapy-induced remodeling of the tumor immune microenvironment. Seminars in cancer biology. 2022 Review GET IT
- Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. Science translational medicine. 2022 Academic Article GET IT
- Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer. NPJ breast cancer. 2022 Academic Article GET IT
- The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group. NPJ breast cancer. 2021 Review GET IT
- LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. Oncoimmunology. 2021 Academic Article GET IT
- 3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine. Nature communications. 2021 Academic Article GET IT
- Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy). Journal of translational medicine. 2021 Academic Article GET IT
-
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?.
Journal for immunotherapy of cancer.
2021
Information Resource
GET IT
Times cited: 158 - The role of radiotherapy in the age of immunotherapy. Japanese journal of clinical oncology. 2021 Information Resource GET IT
- Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer. Journal for immunotherapy of cancer. 2021 Academic Article GET IT
-
Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.
The Journal of clinical investigation.
2021
Academic Article
GET IT
Times cited: 141 -
Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides.
Trends in cancer.
2021
Information Resource
GET IT
Times cited: 2 -
Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates.
Advanced therapeutics.
2020
Academic Article
GET IT
Times cited: 31 -
Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer.
Cancer immunology research.
2020
Academic Article
GET IT
Times cited: 44 -
Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade.
Oncoimmunology.
2020
Academic Article
GET IT
Times cited: 40 -
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant.
Pharmaceutics.
2020
Academic Article
GET IT
Times cited: 12 -
Future of Radiation and Immunotherapy.
International journal of radiation oncology, biology, physics.
2020
Editorial Article
GET IT
Times cited: 5 -
Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1.
International journal of radiation oncology, biology, physics.
2020
Academic Article
GET IT
Times cited: 4 -
IL15 synergizes with radiotherapy to reprogram the tumor immune contexture through a dendritic cell connection.
Oncoimmunology.
2020
Information Resource
GET IT
Times cited: 6 -
Radiation-induced Adaptive Response: New Potential for Cancer Treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Information Resource
GET IT
Times cited: 32 -
Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses.
Cancer immunology research.
2020
Academic Article
GET IT
Times cited: 31 -
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
NPJ breast cancer.
2020
Information Resource
GET IT
Times cited: 15 -
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
NPJ breast cancer.
2020
Academic Article
GET IT
Times cited: 115 - Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group. NPJ breast cancer. 2020 Information Resource GET IT
-
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
The Journal of pathology.
2020
Information Resource
GET IT
Times cited: 43 -
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Journal for immunotherapy of cancer.
2020
Information Resource
GET IT
Times cited: 728 -
The abscopal effect 67 years later: from a side story to center stage.
The British journal of radiology.
2020
Information Resource
GET IT
Times cited: 79 -
CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection.
Cancer immunology research.
2020
Academic Article
GET IT
Times cited: 102 -
Exercise reduces immune suppression and breast cancer progression in a preclinical model.
Oncotarget.
2020
Academic Article
GET IT
Times cited: 81 -
Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment.
Cancer treatment and research.
2020
Article
GET IT
Times cited: 1 -
Aggressive Mammary Cancers Lacking Lymphocytic Infiltration Arise in Irradiated Mice and Can Be Prevented by Dietary Intervention.
Cancer immunology research.
2019
Academic Article
GET IT
Times cited: 10 -
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer.
Journal of the National Cancer Institute.
2019
Academic Article
GET IT
Times cited: 39 -
Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients.
Journal for immunotherapy of cancer.
2019
Academic Article
GET IT
Times cited: 40 -
Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod.
Scientific reports.
2019
Academic Article
GET IT
Times cited: 22 -
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology.
2019
Academic Article
GET IT
Times cited: 136 -
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2019
Academic Article
GET IT
Times cited: 557 -
Radiotherapy induces responses of lung cancer to CTLA-4 blockade.
Nature medicine.
2018
Academic Article
GET IT
Times cited: 691 -
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.
Oncoimmunology.
2018
Academic Article
GET IT
Times cited: 164 -
Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect.
Trends in immunology.
2018
Information Resource
GET IT
Times cited: 350 -
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning.
Seminars in cancer biology.
2018
Information Resource
GET IT
Times cited: 55 -
Cytosolic DNA Sensing in Organismal Tumor Control.
Cancer cell.
2018
Information Resource
GET IT
Times cited: 100 -
Microarray analysis of miRNA expression profiles following whole body irradiation in a mouse model.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
2018
Academic Article
GET IT
Times cited: 33 -
Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs.
Cancer immunology research.
2018
Academic Article
GET IT
Times cited: 271 -
Understanding Responses to Stereotactic Body Radiotherapy and Pembrolizumab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2018
Article
GET IT
Times cited: 7 -
Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2018
Academic Article
GET IT
Times cited: 209 -
Using immunotherapy to boost the abscopal effect.
Nature reviews. Cancer.
2018
Information Resource
GET IT
Times cited: 869 -
Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation.
Radiation research.
2018
Academic Article
GET IT
Times cited: 49 -
Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers.
Seminars in cancer biology.
2017
Information Resource
GET IT
Times cited: 53 -
Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells.
Cancer immunology research.
2017
Academic Article
GET IT
Times cited: 169 -
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
Advances in anatomic pathology.
2017
Information Resource
GET IT
Times cited: 542 -
Immune recognition of irradiated cancer cells.
Immunological reviews.
2017
Information Resource
GET IT
Times cited: 75 -
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
Seminars in cancer biology.
2017
Information Resource
GET IT
Times cited: 147 -
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.
Advances in anatomic pathology.
2017
Information Resource
GET IT
Times cited: 498 -
Trial watch: Immune checkpoint blockers for cancer therapy.
Oncoimmunology.
2017
Information Resource
GET IT
Times cited: 63 -
Toward Precision Radiotherapy for Use with Immune Checkpoint Blockers.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2017
Information Resource
GET IT
Times cited: 141 -
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape.
European journal of cancer.
2017
Information Resource
GET IT
Times cited: 232 -
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.
Nature communications.
2017
Academic Article
GET IT
Times cited: 1270 -
Barriers to Radiation-Induced In Situ Tumor Vaccination.
Frontiers in immunology.
2017
Information Resource
GET IT
Times cited: 152 -
Results of a phase I-II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer.
Oncoimmunology.
2016
Academic Article
GET IT
Times cited: 9 -
Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy.
Nature reviews. Clinical oncology.
2016
Information Resource
GET IT
Times cited: 166 -
Current clinical trials testing the combination of immunotherapy with radiotherapy.
Journal for immunotherapy of cancer.
2016
Academic Article
GET IT
Times cited: 320 - Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015. Journal of translational medicine. 2016 Academic Article GET IT
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology. 2016 Information Resource GET IT
-
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2016
Academic Article
GET IT
Times cited: 130 - Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule. Journal for immunotherapy of cancer. 2016 Academic Article GET IT
-
Radiotherapy: Changing the Game in Immunotherapy.
Trends in cancer.
2016
Information Resource
GET IT
Times cited: 280 -
Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness.
Cancer immunology research.
2016
Academic Article
GET IT
Times cited: 82 -
Subverting misconceptions about radiation therapy.
Nature immunology.
2016
Article
GET IT
Times cited: 1 -
CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy.
EBioMedicine.
2016
Academic Article
GET IT
Times cited: 30 -
Role of Local Radiation Therapy in Cancer Immunotherapy.
JAMA oncology.
2015
Information Resource
GET IT
Times cited: 341 - Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC). Oncoimmunology. 2015 Academic Article GET IT
-
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.
The Lancet. Oncology.
2015
Academic Article
GET IT
Times cited: 373 -
TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity.
Cancer research.
2015
Academic Article
GET IT
Times cited: 440 -
Combination of radiotherapy and immune checkpoint inhibitors.
Seminars in radiation oncology.
2015
Information Resource
GET IT
Times cited: 91 -
Current clinical trials testing combinations of immunotherapy and radiation.
Seminars in radiation oncology.
2015
Information Resource
GET IT
Times cited: 119 - Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014 Information Resource GET IT
-
Combinations of immunotherapy and radiation in cancer therapy.
Frontiers in oncology.
2014
Information Resource
GET IT
Times cited: 203 -
Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes.
Journal for immunotherapy of cancer.
2014
Academic Article
GET IT
Times cited: 27 -
Densely ionizing radiation acts via the microenvironment to promote aggressive Trp53-null mammary carcinomas.
Cancer research.
2014
Academic Article
GET IT
Times cited: 14 -
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2014
Academic Article
GET IT
Times cited: 1047 -
Clinical trial evidence of the antitumor activity of topical imiquimod for breast cancer skin metastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2014
Article
GET IT
Times cited: 7 - Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. Oncoimmunology. 2014 Academic Article GET IT
- The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer. Oncoimmunology. 2013 Academic Article GET IT
- Exploiting the stress response to radiation to sensitize poorly immunogenic tumors to anti-CTLA-4 treatment. Oncoimmunology. 2013 Academic Article GET IT
-
Role of the crosstalk between CTLA-4 and NKG2D in the development of anti-CTLA-4 treatment strategies.
Immunotherapy.
2013
Editorial Article
GET IT
Times cited: 3 -
Combining radiotherapy and cancer immunotherapy: a paradigm shift.
Journal of the National Cancer Institute.
2013
Information Resource
GET IT
Times cited: 843 -
Radiation therapy to convert the tumor into an in situ vaccine.
International journal of radiation oncology, biology, physics.
2012
Editorial Article
GET IT
Times cited: 251 - Radiation as an immunological adjuvant: current evidence on dose and fractionation. Frontiers in oncology. 2012 Academic Article GET IT
-
Invariant NKT cells as novel targets for immunotherapy in solid tumors.
Clinical & developmental immunology.
2012
Information Resource
GET IT
Times cited: 33 -
Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2012
Academic Article
GET IT
Times cited: 132 -
Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.
The Journal of clinical investigation.
2012
Academic Article
GET IT
Times cited: 168 -
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2012
Academic Article
GET IT
Times cited: 187 -
TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2011
Academic Article
GET IT
Times cited: 206 -
The numbers of FoxP3+ lymphocytes in sentinel lymph nodes of breast cancer patients correlate with primary tumor size but not nodal status.
Cancer investigation.
2011
Academic Article
GET IT
Times cited: 16 -
Defining the role of the immune system in cancer treatment: highlights from the Immunochemotherapy Conference.
Expert review of anticancer therapy.
2011
Conference Paper
GET IT
Times cited: 2 -
Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?.
Cancer immunology, immunotherapy : CII.
2011
Academic Article
GET IT
Times cited: 27 -
Cancer and inflammation: promise for biologic therapy.
Journal of immunotherapy (Hagerstown, Md. : 1997).
2010
Information Resource
GET IT
Times cited: 274 -
Radiotherapy enhances antitumor effect of anti-CD137 therapy in a mouse Glioma model.
Radiation research.
2010
Academic Article
GET IT
Times cited: 57 -
Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation.
Radiation research.
2010
Academic Article
GET IT
Times cited: 135 -
Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2009
Academic Article
GET IT
Times cited: 1349 -
Systemic effects of local radiotherapy.
The Lancet. Oncology.
2009
Information Resource
GET IT
Times cited: 807 -
Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2009
Academic Article
GET IT
Times cited: 83 -
Local control by radiotherapy: is that all there is?.
Breast cancer research : BCR.
2008
Information Resource
GET IT
Times cited: 56 -
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.
Journal of immunology (Baltimore, Md. : 1950).
2008
Academic Article
GET IT
Times cited: 596 -
Effects of chemoradiation on tumor-host interactions: the immunologic side.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2008
Article
GET IT
Times cited: 33 -
Sensors of ionizing radiation effects on the immunological microenvironment of cancer.
International journal of radiation biology.
2007
Information Resource
GET IT
Times cited: 93 -
The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2006
Academic Article
GET IT
Times cited: 111 -
Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain.
Laboratory investigation; a journal of technical methods and pathology.
2005
Academic Article
GET IT
Times cited: 103 -
Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2005
Academic Article
GET IT
Times cited: 672 -
Select forms of tumor cell apoptosis induce dendritic cell maturation.
Journal of leukocyte biology.
2004
Academic Article
GET IT
Times cited: 52 -
HLA-A2-restricted CD8+-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase.
Infection and immunity.
2004
Academic Article
GET IT
Times cited: 42 -
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.
International journal of radiation oncology, biology, physics.
2004
Academic Article
GET IT
Times cited: 801 -
Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2001
Academic Article
GET IT
Times cited: 230 -
Peptide loading of nascent MHC class I molecules.
Archivum immunologiae et therapiae experimentalis.
2001
Information Resource
GET IT
Times cited: 4 -
Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2000
Academic Article
GET IT
Times cited: 119 -
Soluble HLA proteins with bound peptides are released from the cell surface by the membrane metalloproteinase.
Human immunology.
2000
Academic Article
GET IT
Times cited: 24 -
Peptide-conformed beta2m-free class I heavy chains are intermediates in generation of soluble HLA by the membrane-bound metalloproteinase.
Human immunology.
1999
Academic Article
GET IT
Times cited: 14 -
The metalloproteinase-mediated pathway is essential for generation of soluble HLA class I proteins by activated cells in vitro: proposed mechanism for soluble HLA release in transplant rejection.
Human immunology.
1998
Academic Article
GET IT
Times cited: 24 -
Soluble CD4 induces the binding of human immunodeficiency virus type 1 to cells via the V3 loop of glycoprotein 120 and specific sites in glycoprotein 41.
AIDS research and human retroviruses.
1996
Academic Article
GET IT
Times cited: 14 -
Bathophenanthroline disulfonate and soluble CD4 as probes for early events of HIV type 1 entry.
AIDS research and human retroviruses.
1995
Academic Article
GET IT
Times cited: 5 -
Soluble beta 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease.
The Journal of biological chemistry.
1994
Academic Article
GET IT
Times cited: 81 -
CD8 and beta 2-microglobulin-free MHC class I molecules in T cell immunoregulation.
International journal of clinical & laboratory research.
1993
Information Resource
GET IT
Times cited: 22 -
The origin and fate of beta 2m-free MHC class I molecules induced on activated T cells.
Cellular immunology.
1992
Academic Article
GET IT
Times cited: 46 -
Activation of human CD8-positive T cells via the CD8/HLA class I complex.
Cellular immunology.
1990
Academic Article
GET IT
Times cited: 4 -
Increased density of ecto 5' nucleotidase antigen on leukemic T cells from patients with cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
Blood.
1989
Academic Article
GET IT
Times cited: 18 -
Physical association between the CD8 and HLA class I molecules on the surface of activated human T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America.
1988
Academic Article
GET IT
Times cited: 66 -
Definition by CB12 monoclonal antibody of a differentiation marker specific for human monocytes and their bone marrow precursors.
Cellular immunology.
1986
Academic Article
GET IT
Times cited: 4 -
Functional and molecular characterization by the CB04 monoclonal antibody of a cell surface structure exerting C3-complement receptor activity.
Journal of clinical immunology.
1985
Academic Article
GET IT
Times cited: 8 -
Murine monoclonal antibodies as probes for the phenotypical, functional, and molecular analysis of a discrete peripheral blood lymphocyte population exerting natural killer activity in vitro.
Human immunology.
1985
Academic Article
GET IT
Times cited: 26